4:20 PM ET
8-K
Leadership Change
Halozyme Therapeutics Leadership Change
Halozyme Therapeutics appointed James Daly to its Board of Directors, effective September 28, 2026. Mr. Daly will serve in the class of directors with a term ending at the 2029 annual meeting and will receive standard compensation under the company's non-employee director program.
- Counterparty
- James Daly